The National Academies is inviting public comments on a Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, part of a fast track study commissioned by the National Institutes of Health and the Centers for Disease Control and Prevention. The study will recommend priorities to inform allocation of a limited initial supply of COVID-19 vaccine, taking into account factors such as racial/ethnic inequities and groups at higher risk from COVID-19 due to health status, occupation, or living conditions (see the study webpage for the complete project description).
Input from the public, especially communities disproportionately affected by COVID-19, is essential to produce a final report that is objective, balanced, and inclusive. I hope you or your organization will consider making a comment on behalf of your constituents. I also encourage you to share this opportunity with others in your network.
The discussion draft will be available for public comment for 4 days, from 12:00 pm ET on Tuesday, September 1, until 11:59 pm ET on Friday, September 4. The discussion draft will comprise a preliminary vaccine allocation framework, including priority recipient groups. Commenters will be able to download and review the discussion draft before submitting comments through an online form. All materials and comments received will be placed in the committee’s Public Access File, and may be provided to the public upon request. You will be able to access the discussion draft and public comment form here: www.nationalacademies.org/VaccineAllocationComment.
For more information, please visit the study webpage. To receive a reminder when the public comment period opens, please ensure that you have registered for our COVID-19 & Infectious Diseases mailing list. You can also follow us on Twitter at @theNAMedicine and @theNASEM or email COVIDVaccineFramework@nas.edu.
Thanks for your consideration. We look forward to hearing from you at www.nationalacademies.org/VaccineAllocationComment.